ArticleCancers2024

Mapping the Anti-Cancer Activity of α-Connexin Carboxyl-Terminal (aCT1) Peptide in Resistant HER2+ Breast Cancer.

Kimberly M Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.